PDRN and Polyglutamic Acid: The Hydration Amplifier for Enhanced PDRN Delivery

PDRN (polydeoxyribonucleotide) operates at the dermal level, requiring adequate hydration for optimal penetration and biological activity. When PGA is layered over PDRN, its moisture film serves as a hydration reservoir that keeps the PDRN serum in a wet, active state on the skin for longer, promoting sustained absorption rather than rapid evaporation. This is particularly important because PDRN's mechanisms — A2A receptor binding, fibroblast stimulation, and nucleotide salvage pathway activation — are all hydration-dependent biological processes that function optimally in a well-hydrated tissue environment.

Beyond the delivery-enhancement effect, PGA provides its own skin benefits that complement PDRN's regenerative properties. PGA inhibits hyaluronidase, the enzyme that degrades hyaluronic acid in the skin, thereby preserving the skin's natural hyaluronic acid reserves and maintaining dermal hydration. This hyaluronidase-inhibiting property means PGA doesn't just add moisture — it helps the skin retain its own moisture molecules for longer. Combined with PDRN's ability to stimulate fibroblast activity and extracellular matrix production, the pair creates a dual hydration strategy: PGA preserves existing moisture reserves while PDRN rebuilds the structural matrix that holds moisture in place.

This combination is ideal for dehydrated skin at any age, patients using drying treatments (retinoids, acids), those in arid or air-conditioned environments, and anyone seeking to maximize the efficacy of their PDRN products through enhanced delivery and hydration support.